Axsome Therapeutics Inc (AXSM)
71.21
-1.89
(-2.59%)
USD |
NASDAQ |
Apr 24, 16:00
71.21
0.00 (0.00%)
After-Hours: 16:58
Axsome Therapeutics Market Cap: 3.374B for April 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 23, 2024 | 3.463B |
| April 22, 2024 | 3.368B |
| April 19, 2024 | 3.217B |
| April 18, 2024 | 3.113B |
| April 17, 2024 | 3.302B |
| April 16, 2024 | 3.260B |
| April 15, 2024 | 3.231B |
| April 12, 2024 | 3.276B |
| April 11, 2024 | 3.398B |
| April 10, 2024 | 3.362B |
| April 09, 2024 | 3.441B |
| April 08, 2024 | 3.416B |
| April 05, 2024 | 3.423B |
| April 04, 2024 | 3.419B |
| April 03, 2024 | 3.482B |
| April 02, 2024 | 3.532B |
| April 01, 2024 | 3.647B |
| March 28, 2024 | 3.780B |
| March 27, 2024 | 3.751B |
| March 26, 2024 | 3.635B |
| March 25, 2024 | 3.664B |
| March 22, 2024 | 3.821B |
| March 21, 2024 | 3.831B |
| March 20, 2024 | 3.735B |
| March 19, 2024 | 3.642B |
| Date | Value |
|---|---|
| March 18, 2024 | 3.437B |
| March 15, 2024 | 3.579B |
| March 14, 2024 | 3.304B |
| March 13, 2024 | 3.311B |
| March 12, 2024 | 3.287B |
| March 11, 2024 | 3.360B |
| March 08, 2024 | 3.502B |
| March 07, 2024 | 3.413B |
| March 06, 2024 | 3.418B |
| March 05, 2024 | 3.630B |
| March 04, 2024 | 3.705B |
| March 01, 2024 | 3.905B |
| February 29, 2024 | 3.855B |
| February 28, 2024 | 3.930B |
| February 27, 2024 | 3.979B |
| February 26, 2024 | 3.899B |
| February 23, 2024 | 3.740B |
| February 22, 2024 | 3.812B |
| February 21, 2024 | 3.890B |
| February 20, 2024 | 3.844B |
| February 16, 2024 | 4.397B |
| February 15, 2024 | 4.428B |
| February 14, 2024 | 4.420B |
| February 13, 2024 | 4.371B |
| February 12, 2024 | 4.623B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
534.22M
Minimum
Apr 24 2019
4.623B
Maximum
Feb 12 2024
2.338B
Average
2.612B
Median
Market Cap Benchmarks
| Amgen Inc | 146.37B |
| Johnson & Johnson | 357.95B |
| ResMed Inc | 27.04B |
| Vertex Pharmaceuticals Inc | 103.51B |
| Krystal Biotech Inc | 4.533B |
Market Cap Related Metrics
| PS Ratio | 11.95 |
| Price to Book Value | 17.66 |
| Price | 71.21 |
| Earnings Yield | -7.30% |